Search results for "Biological product"

showing 10 items of 126 documents

Microbial communities of the Mediterranean rocky shore: ecology and biotechnological potential of the sea‐land transition

2019

Microbial communities from harsh environments hold great promise as sources of biotechnologically relevant strains and compounds. In the present work, we have characterized the microorganisms from the supralittoral and splash zone in three different rocky locations of the Western Mediterranean coast, a tough environment characterized by high levels of irradiation and large temperature and salinity fluctuations. We have retrieved a complete view of the ecology and functional aspects of these communities and assessed the biotechnological potential of the cultivable microorganisms. All three locations displayed very similar taxonomic profiles, with the genus Rubrobacter and the families Xenoco…

Microbiological TechniquesMediterranean climatelcsh:BiotechnologyBioengineeringApplied Microbiology and BiotechnologyBiochemistrySupralittoral zoneAntioxidants03 medical and health sciencesRocky shoreAscomycotaMicrobial ecologylcsh:TP248.13-248.65Environmental MicrobiologyAnimals14. Life underwaterCaenorhabditis elegansRhodobacteraceaeResearch Articles030304 developmental biologyBiological Products0303 health sciencesBacteriabiologyMediterranean Region030306 microbiologyPhyllobacteriaceaeEcologyMicrobiota15. Life on landbiology.organism_classificationArchaeaSurvival Analysis13. Climate actionHalotoleranceResearch ArticleBiotechnologyArchaea
researchProduct

QSAR of Natural Sesquiterpene Lactones as Inhibitors of Myb-dependent Gene Expression

2017

Background Protein c-Myb is a therapeutic target. Some sesquiterpene lactones suppress Myb-dependent gene expression, which results in their potential anti-cancer activity. Material & methods Database ChEMBL is a representative of lactones for physicochemical and physiochemical properties. Data presented for 31 natural lactones are discussed in terms of quantitative structureactivity relationships with the objective to predict inhibitors of Myb-induced gene expression. Several constitutional descriptors are related to structure-activity. α-Methylene-γ-lactone groups enhance while OH functions worsen potency. The latter feature is in agreement with the fact that the more lipophilic the lacto…

Models Molecular0301 basic medicine030103 biophysicsQuantitative structure–activity relationshipStereochemistryQuantitative Structure-Activity RelationshipSesquiterpene lactoneSesquiterpeneLactonesProto-Oncogene Proteins c-myb03 medical and health scienceschemistry.chemical_compoundDrug DiscoveryGene expressionHumansStructure–activity relationshipMYBCytotoxicitychemistry.chemical_classificationBiological ProductsDose-Response Relationship DrugMolecular StructureCationic polymerizationGeneral MedicinechEMBLGene Expression RegulationchemistrySesquiterpenesLactoneCurrent Topics in Medicinal Chemistry
researchProduct

An Experimental Toolbox for Structure‐Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics

2021

Abstract FabF (3‐oxoacyl‐[acyl‐carrier‐protein] synthase 2), which catalyses the rate limiting condensation reaction in the fatty acid synthesis II pathway, is an attractive target for new antibiotics. Here, we focus on FabF from P. aeruginosa (PaFabF) as antibiotics against this pathogen are urgently needed. To facilitate exploration of this target we have set up an experimental toolbox consisting of binding assays using bio‐layer interferometry (BLI) as well as saturation transfer difference (STD) and WaterLOGSY NMR in addition to robust conditions for structure determination. The suitability of the toolbox to support structure‐based design of FabF inhibitors was demonstrated through the …

Models MolecularBio-layer interferometrymedicine.drug_classAntibioticsMicrobial Sensitivity TestsCrystallography X-RayLigandsBiochemistryantibiotics3-Oxoacyl-(Acyl-Carrier-Protein) SynthaseDrug Discoverymedicinebio-layer interferometryGeneral Pharmacology Toxicology and PharmaceuticsEnzyme InhibitorsPharmacologyligand-based NMRVirtual screeningBiological ProductsFull PaperMolecular StructureChemistryOrganic ChemistryLimitingFull Papersvirtual screeningCombinatorial chemistrystructure-based designAnti-Bacterial AgentsSaturation transferPseudomonas aeruginosaMolecular MedicineStructure basedChemmedchem
researchProduct

Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and m…

2019

Abstract Over the latest years phytochemical consumption has been associated to a decreased risk of both the onset and the development of a number of pathological conditions. In this context indicaxanthin, a betalain pigment from Opuntia ficus-indica fruit, has been the object of sound research. Explored, at first, for its mere antioxidant potential, Indicaxanthin is now regarded as a redox-active compound able to exert significant poly-pharmacological effects against several targets in a number of experimental conditions both in vivo and in vitro. This paper aims to provide an overview on the therapeutical effects of indicaxanthin, ranging from the anti-inflammatory to the neuro-modulatory…

Models MolecularPyridinesOpuntia ficusPhytochemicalsContext (language use)Antioxidant potential01 natural sciencesMiceStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compoundMulti targetCell Line TumorNeoplasmsSettore BIO/10 - BiochimicaBetalainDrug DiscoveryAnimalsHumansCell Proliferation030304 developmental biologyInflammationIndicaxanthin Multi-target compound Poly-pharmacology Antioxidant Antiinflammatory Antitumoral Antiproliferative Neuromodulator Molecular modellingPharmacologyBiological Products0303 health sciencesDose-Response Relationship DrugMolecular StructureTraditional medicine010405 organic chemistryNatural compoundOrganic ChemistryOpuntiaGeneral MedicineAntineoplastic Agents PhytogenicSettore CHIM/08 - Chimica FarmaceuticaBetaxanthins0104 chemical sciencesMice Inbred C57BLNeuroprotective AgentsPhytochemicalchemistryBlood-Brain BarrierFruitDrug Screening Assays AntitumorIndicaxanthinEuropean Journal of Medicinal Chemistry
researchProduct

Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products.

2010

Personalized cancer medicine aims to develop individualized treatment options adapted to factors relevant for the prognosis of each patient. Molecular biomarkers are required to predict the likelihood of an individual tumor's responsiveness or of toxicity in normal organs and to advise optimized treatments with improved efficacy at reduced side effects for each cancer patient. In the present review, we present a concept, which takes advantage of methods of molecular diagnostics to identify predictive markers at the DNA, mRNA, and protein levels. Markers with prognostic value concerning treatment response and patient survival can then be used as targets to develop optimized drugs. We focus o…

Oncologymedicine.medical_specialtyPathologymedicine.medical_treatmentPharmaceutical ScienceDrug resistanceAnalytical ChemistryTargeted therapyCytogeneticsInternal medicineNeoplasmsDrug DiscoverymedicineBiomarkers TumorHumansEpidermal growth factor receptorATP Binding Cassette Transporter Subfamily B Member 1RNA MessengerPrecision MedicinePharmacologyChemotherapyBiological ProductsAlanineAntibiotics Antineoplasticbiologybusiness.industryOrganic ChemistryCancerGenetic VariationMolecular diagnosticsmedicine.diseaseErbB ReceptorsComplementary and alternative medicineDrug Resistance NeoplasmPharmacogenomicsbiology.proteinMolecular MedicinebusinessComparative genomic hybridizationPhytotherapyPlanta medica
researchProduct

Antibacterial activity of Mediterranean Oyster mushrooms, species of genus Pleurotus (higher Basidiomycetes).

2013

Extracts of the Mediterranean culinary-medicinal Oyster mushrooms Pleurotus eryngii var. eryngii, P. eryngii var. ferulae, P. eryngii var. elaeoselini, and P. nebrodensis were tested for their in vitro growth inhibitory activity against a group of bacterial reference strains of medical relevance: Staphylococcus aureus ATCC 25923, S. epidermidis RP62A, Pseudomonas aeruginosa ATCC 15442, and Escherichia coli ATCC10536. All of the Pleurotus species analyzed inhibited the tested microorganisms in varying degrees. The data included in this paper for P. nebrodensis and P. eryngii var. elaeoselinii are new reports.

OysterMicroorganismStaphylococcusHuman pathogenmedicine.disease_causePleurotusApplied Microbiology and BiotechnologySpecies Specificitybiology.animalDrug DiscoveryBotanymedicineEscherichia coliPleurotus eryngiiFood scienceEscherichia coliPharmacologyPleurotusBiological Productsbiologybiology.organism_classificationAnti-Bacterial AgentsStaphylococcus aureusSettore BIO/03 - Botanica Ambientale E ApplicataPseudomonas aeruginosamedicinal mushrooms antibacterial activity Pleurotus human pathogensAntibacterial activityAgaricalesInternational journal of medicinal mushrooms
researchProduct

Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy

2012

An area of therapeutic interest in cancer biology and treatment is targeting the cancer stem cell, more appropriately referred to as the cancer initiating cell (CIC). CICs comprise a subset of hierarchically organized, rare cancer cells with the ability to initiate cancer in xenografts in genetically modified murine models. CICs are thought to be responsible for tumor onset, self-renewal/maintenance, mutation accumulation and metastasis. CICs may lay dormant after various cancer therapies which eliminate the more rapidly proliferating bulk cancer (BC) mass. However, CICs may remerge after therapy is discontinued as they may represent cells which were either intrinsically resistant to the or…

PTENgerminal mutationchemotherapeuticmedicine.medical_treatmentAntineoplastic AgentsPI3KTargeted therapyMetastasisMice03 medical and health sciencesTARGETED THERAPY0302 clinical medicineCancer stem cellNeoplasmsradiologicalDrug DiscoverymedicineAnimalsHumansPTENAkt; mTOR; PI3K; PTEN; Targeted therapy; Therapeutic sensitivityPI3K/AKT/mTOR pathway030304 developmental biologyPharmacologyBiological Products0303 health sciencesbiologyAKTMTORAktCD44Wnt signaling pathwayCancertargeted therapymedicine.disease3. Good healththerapeutic sensitivityxenografts030220 oncology & carcinogenesisImmunologymTORNeoplastic Stem CellsCancer researchbiology.proteinCurrent Pharmaceutical Design
researchProduct

Clinical outcomes of veneered zirconia anterior partial fixed dental prostheses: A 12-year prospective clinical trial

2019

Abstract Statement of problem Anterior veneered zirconia partial fixed dental prostheses (FDPs) have substituted for metal-ceramic to improve esthetics and biocompatibility. However, the material is susceptible to aging or hydrothermal degradation and to chipping of the feldspathic veneer. Whether these susceptibilities limit the clinical performance of anterior veneered zirconia FPDs is unclear. Purpose The purpose of this prospective clinical study was to analyze the mechanical and biologic behavior of zirconia partial FDPs in the anterior region over a 12-year follow-up period. Material and methods Twenty-seven 3- to 6-unit FDPs fabricated from zirconia veneered with feldspathic porcelai…

Periapical pathologyDentistryDental CariesEsthetics DentalAnterior regionDental Materials03 medical and health sciences0302 clinical medicinePeriodontal diseaseHumansMedicineDental Restoration FailureProspective StudiesSurvival rateBiological Productsbusiness.industryDental prosthesisClinical performance030206 dentistryDental PorcelainClinical trialDental VeneersDenture Partial FixedZirconiumOral SurgeryComplicationbusinessThe Journal of Prosthetic Dentistry
researchProduct

Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview.

2021

Abstract Natural products and synthetic analogs have drawn much attention as potential therapeutical drugs to treat metabolic syndrome. We reviewed the underlying mechanisms of 32 natural products and analogs with potential pharmacological effects in vitro, and especially in rodent models and/or patients, that usually act on the PPAR pathway, along with other molecular targets. Recent outstanding total syntheses or semisyntheses of these lead compounds are stated. In general, they can activate the transcriptional activity of PPARα, PPARγ, PPARα/γ, PPARβ/δ, PPARα/δ, PPARγ/δ and panPPAR as weak, partial agonists or selective PPARγ modulators (SPPARγM), which may be useful for managing obesity…

Peroxisome Proliferator-Activated ReceptorsPeroxisome proliferator-activated receptorPharmacologyResveratrol01 natural sciences03 medical and health scienceschemistry.chemical_compoundStructure-Activity RelationshipBerberineDrug DiscoverymedicineAnimalsHumansReceptor030304 developmental biologyPharmacologychemistry.chemical_classificationMetabolic Syndrome0303 health sciencesBiological ProductsDose-Response Relationship DrugMolecular Structure010405 organic chemistryChemistryOrganic ChemistryGeneral MedicinePPAR Pathwaymedicine.disease0104 chemical sciencesCurcuminQuercetinDyslipidemiaEuropean journal of medicinal chemistry
researchProduct

Natural Products and Inflammation

2017

Inflammation (or inflammatory reaction) is the response to body aggression by a pathogen agent, an allergen, a toxic compound, a tissue lesion, etc.[...]

Pharmaceutical ScienceInflammation010402 general chemistrymedicine.disease_cause01 natural sciencesAnalytical ChemistryLesionlcsh:QD241-441Allergenlcsh:Organic chemistryDrug DiscoveryHumansMedicinePhysical and Theoretical ChemistryPathogenInflammationBiological Products010405 organic chemistrybusiness.industryAggressionOrganic Chemistry0104 chemical sciencesEditorialn/aChemistry (miscellaneous)ImmunologyMolecular Medicinemedicine.symptombusinessMolecules
researchProduct